A Pilot Study of Nuclear Factor-Kappa B (NFkB) Inhibition During Induction Chemotherapy for Patients With Acute Myelogenous Leukemia (AML).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Choline magnesium trisalicylate (Primary) ; Dexamethasone (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 19 Nov 2013 Biomarkers information updated
- 17 Nov 2009 Actual end date (Aug 2008 ) added as reported by ClinicalTrials.gov.
- 21 Aug 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.